Mini BAL v/s Bronchoscopic BAL PROF. PRADYUT WAGHRAY MD (CHEST), DTCD, FCCP (USA),D.SC(PULM. MEDICINE) HEAD OF DEPT. OF PULMONARY MEDICINE S.V.S MEDICAL.

Slides:



Advertisements
Similar presentations
The Eradication of VAP in Scotland Martin Hughes Nov 2010.
Advertisements

Prevention of Ventilator Associated Pneumonia
Rare Film Guide Slide Set. Clinical Trial Design for Pirfenidone Study Purpose of Study: To see if the use of pirfenidone decreases the loss of lung function.
VENTILATOR – ACQUIRED PNEUMONIA Professor of Respiratory Medicine
Reducing Ventilator Associated Pneumonia in Adults Intensive Care Units Confidential: Quality Improvement Material.
Pulmonary Tuberculosis and Lung Cancer. Diagnosis of Primary Tumor  Sputum Cytology  Flexible Bronchoscopy and Biopsy  TTNA transthoracic needle aspiration.
Sahar Elkaradawy Assistant Professor in Anaesthesia and Intensive Care Unite.
Ventilator-Associated Pneumonia. Introduction Definition 48 hours after intubation mechanically ventilated No clinical evidence of pneumonia prior to.
Journal Club. Background to the paper Pneumonia is THE MOST COMMON nosocomial infection in ICU patients 12 to 18 cases per 1000 ventilator days Oropharyngeal.
1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.
Preparation for postural drainage
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Nebulized Hypertonic Saline for Bronchiolitis Florin TA, Shaw KN, Kittick M, Yakscoe.
Early detection of pulmonary involvement in scleroderma patients By Mohamed Mostafa Metwally, MD, FCCP Assistant professor of chest diseases Assiut University.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Copyright © 2008 Delmar Learning. All rights reserved. Unit 39 Respiratory System.
Dr. Paramita Sengupta Department Of Community Medicine Christian Medical College Ludhiana Co-authors: Ragini Mann, Rohit Theodore, A I Benjamin Risk factors.
Standard and Expanded Precautions
Oral Care for Patients at Risk for Ventilator-Associated Pneumonia Issued April 2010.
Karin Schurink Peter Lucas Marc Bonten Stefan Visscher Incorporating Evaluation into the Design of a Decision-Support System UMC Utrecht Radboud University.
MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII INFECTION IN RESPIRATORY INTENSIVE CARE UNIT Pervin Korkmaz Ekren 1, M. Sezai Tasbakan 1, Burcu Basarık 1,
Iatrogenic Anemia in the ICU Anh Nguyen, MD, MPH, PGY2.
Chapter 22 Pulmonary Infections. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Objectives  State the incidence.
Part I BACKGROUND VENTILATOR ASSOCIATED PNEUMONIA.
Pneumonia Dr. Abdul-Monim Batiha Assistant Professor Critical Care Nursing Philadelphia university.
Nosocomial Pneumonia Epidemiology Common hospital-acquired infection Occurs at a rate of approximately 5-10 cases per 1000 hospital admissions Incidence.
Monthly Journal article review: Vimmi Kang PGY 2
The study of Pathogens causing Community Acquired Pneumonia in hematological malignancy patients comparing to general patients who hospitalized in Naresuan.
Follow Up on Daily Xray for Intubated Patients Sebastian Benavides 12/10/2012.
TEMPLATE DESIGN © Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to COPD.
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
Stool Cultures Hemoccult Gastroccult Sputum Cultures.
Prepared by : Salwa Maghrabi Teacher Assistant Nursing Department
Pneumonia Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Introduction Infection involving the.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
1 EFFICACY OF SHORT COURSE AMOXICILLIN FOR NON-SEVERE PNEUMONIA IN CHILDREN (Hazir T*, Latif E*, Qazi S** AND MASCOT Study Group) *Children’s Hospital,
Poster Design & Printing by Genigraphics ® A Comparison of the Effects of Etomidate and Midazolam on the Duration of Vasopressor Use in.
Ventilator-associated pneumonia (VAP) Ventilator-associated pneumonia (VAP) is defined as nosocomial pneumonia in a patient on mechanical ventilatory support.
Sunil Kumar, B.K.Kapoor, Urvinderpal Singh, Vidhu Mittal Department of Pulmonary Medicine, GMC,Patiala PRESENTATION OF PULMONARY TUBERCULOSIS IN ELDERLY.
Outcome of Increasingly Morbid Cardiac Patients Prof. Abdulhamid Al-Saeed, FFARCSI Professor in Anaesthesia & Critical Care Medicine Head of Cardiac Anaesthesia.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Prepared by : Dr. Irene Roco
R3 정수웅. Introduction Community-acquired pneumonia − Leading infectious cause of death in developed countries − The mortality in patients with treatment.
ICU Nosocomial Pneumonia
Nosoref: a French survey of nosocomial infections (NI) surveillance in intensive care units (ICU) F L’Hériteau 1, C Alberti 2, G Troché 3, P Moine 4, Y.
Ventilator Associated Pneumonia. Ventilator-associated pneumonia (VAP) is a form of hospital-associated pneumonia (HAP) which develops in mechanically.
Using Subglottic Endotracheal Tubes in Preventing Ventilator Assisted Pneumonia By: Nicole Durrance, Adriana Gomez, Esther Gonzalez, Marzette Solis BACKGROUND.
Is a Strategy Based on Routine Endotracheal Cultures the Best Way to Prescribe Antibiotics in Ventilator-Associated Pneumonia? CHEST 2013; 144(1):63-71.
Poster template by ResearchPosters.co.za Ventilator Associated Pneumonia rates in Intensive Care. Lori J. Delaney Assistant Professor: University of Canberra,
Bronchoscopy-Guided Topical Hemostatic Tamponade Therapy for the management of Life-Threatening Hemoptysis Arschang Valipour,MD:Alois Kreuzer,MD:Hubert.
Depart. Of Pulmonology and Critical Care Medicine R4 백승숙.
Quality Management in the ICU Mazen Kherallah, MD, FCCP Chairman, Critical Care Department King Faisal Specialist Hospital & Research Center.
Stents Are Associated With Increased Risk of Respiratory Infections in Patients Undergoing Airway Interventions for Malignant Airways Disease Horiana B.
Ventilator-associated Pneumonia Among Elderly Medicare Beneficiaries in Long-term Care Hospitals William Buczko, Ph.D. Research Analyst Centers for Medicare.
Comparison between pathogen directed antibiotic treatment and empiri cal broad spectrum antibiotic treatment in patients with community acquired pneumonia.
Pattern of Hospital-Acquired Pneumonia in Intensive Care Unit of Suez Canal University Hospital By Nermine El-Maraghy Associate Professor of Medical Microbiology.
Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients B J Philips, J Redman, A Brennan, D Wood, R Holliman, D Baines,
ALC, Pneumonia, COPD, Strokes
New WHO algorithm to prevent TB deaths in seriously ill patients with HIV Yohhei Hamada TB/HIV and Community Engagement.
Hospital-acquired Pneumonia
Universidad Militar Nueva Granada, School of Medicine
A Quick Review: Preventing Ventilator-Associated Pneumonia (VAP)
Hospital acquired infections/ Nosocomial infections
Fundamentals of Bronchoscopy: BRONCHIAL BRUSHING
Ms. SHINY THOMAS STAFF NURSE NEUROSURGERY ICU JPNATC, AIIMS New Delhi
Surveillance of Post-operative pneumonia
Prophylaxis of Ventilator-Associated Pneumonia
Ordering Sputum Cultures in Community Acquired Pneumonia
Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures  B. Herer, C. Fuhrman, Z. Gazevic,
Airway Suctioning NUR 422.
Presentation transcript:

Mini BAL v/s Bronchoscopic BAL PROF. PRADYUT WAGHRAY MD (CHEST), DTCD, FCCP (USA),D.SC(PULM. MEDICINE) HEAD OF DEPT. OF PULMONARY MEDICINE S.V.S MEDICAL COLLEGE, MAHABUBNAGAR TELANGANA STATE DIRECTOR KUNAL INSTITUTE OF MEDICAL SPECIALITIES PVT. LTD BASHEERBAGH, HYDERABAD

Introduction  Patients in the intensive care unit (ICU) are at risk for dying not only from their critical illness but also from secondary processes such as nosocomial infection.  Pneumonia is the second most common nosocomial infection in critically ill patients, affecting 27% of all critically ill patients.  86 % percent of nosocomial pneumonias are associated with mechanical ventilation and are termed ventilator-associated pneumonia (VAP).  The mortality attributable to VAP has been reported to range between 0 and 70%.

 Early diagnosis and treatment is vital for lowering the high mortality rates.  Unfortunately, the accurate diagnosis of VAP remains a challenge for the clinicians due to the fact that clinical, radiological and microbiological findings have low sensitivity and specifity.  Diagnosis as a practicable method in centers not using tracheal aspirate, has low specificity and high false positive rates due to upper respiratory tract (way) contamination.  Mini-non-bronchoscopic, protected BAL, protected specimen brush (mini-BAL, PSB) has low contamination probability so it could provide higher sensitive and specific results.

Method  Study design  Totally 60 patients were included in the study.  Among 60 patients in 30 patients bronchoscopic bal was done, in the remaining 30 minibal was done.  The procedure to be done i.e either bronchoscopic bal or minibal in intubated patients was randomly selected  INCLUSION CRITERIA:  patients who developed area of consolidation on x ray, with fever, leucocytosis and purulent secretions on suctioning and age18-60 years were included in the study.

 EXCLUSION CRITERIA:  Patients who had consolidation before intubation, immunocompromised status, HIV seropositive, those with cancer, age 60 were excluded.  The organisms isolated, response to treatment and number of patients who died were noted.

Procedure  In patients satisfying the inclusion criteria consent was taken and either minibal or bronchoscopic bal was done.  MINIBAL:  Also referred to as blind BAL or non-bronchoscopic BAL was done by using foleys catheter, mucus trap and suction.  First the Fio2 was increased to 100%, 15 minutes prior to the procedure.  A foleys catheter was passed through the ET tube directed towards the side required.

 20 ml of saline was flushed through the catheter, then it was connected to mucus trap and NS was collected using suction.  This was repeated till the sample was sufficient.  The procedure was stopped as soon as saturation fell below 90%.  The sample was sent for necessary investigations.  BRONCHOSCOPIC BAL:  The procedure was same as above except that bronchoscope was used instead of foleys catheter.  BAL fluid collected and sent for investigation.

Statistical analysis Comparision of isolated organism in bronchscopic BAL that with Mini BAL

MRSA Pseudomonas Klebsiella E. Coli S.Pneumnae Candida

MRSA Pseudomonas Klebsiella E. Coli S.Pneumnae Candida

Results  Of the total 60 patients, 22 were females and 38 were males.  Each group had 11 females and 19 males.  In patients who underwent minibal 24 out of 30 patients showed growth of organisms (80%) ;  in patients underwent bronchoscopic bal, 26 out of 30 showed growth(86.6%).  The isolated organisms in bronchoscopic BAL were MRSA -10(41.6%), Pseudomonas -6(25%), Klebsiella - 4 (16.6%),E.coli - 1(4.1%), S.pneumonae - 2(8.3%), Candida - 1(4.1%).  The organisms isolated by mini BAL were MRSA - 8(30.7%), pseudomonas- 6(23%), klebsiella - 5(19.2%), E.coli - 4(15.3%), S.pneumoniae - 2(7.7%), candida- 1(3.8%).

Discussion  Pneumonia is the major cause of morbidity in ventilated patients.  various techniques like tracheal aspirate, bronchoscopic BAL, protected brush specimens, minibal have been used to obtain microbiological samples.  Invasive tests such as bronchoscopic BAL or protected specimen brush (PSB) may avoid the extended use of antibiotics for clinically insignificant organisms, but no direct consensus or evidence suggests that one test is superior to the other.

 The advanteges of bronchoscopy procedure are - specifically affected areas of the lung can be visualized and sampled, more accurate than sputum or tracheal aspirates, may enable physician to identify non-infectious lesions.  The advantages of minibal are - it may be performed by a trained Nurse or Respiratory Therapist, reducing any delay and cost, no assistants or extra equipment are required. Sensitivity and specificity is comparable with bronchoscopic BAL and PSB, and no potential safety concerns of resterilization of equipment

Conclusion  In our study, minibal was compared with bronchoscopic BAL in intubated patients.  Organisms were isolated in 80% of patients who had minibal done and in 86.6% patients who had bronchoscopy done.  The sensitivities of isolating organisms by minibal and bronchoscopic BAL is almost similar in our study.  Hence minibal may be used in areas where bronchoscope is not available with minimal cost.

Thank you